Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grant Dewson

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
The EMBO Journal|September 15, 2021
Dynamic reconfiguration of pro-apoptotic BAK on membranesJarrod J Sandow, Iris Kl Tan, Alan S Huang, et al.
Nature Immunology|July 10, 2007
Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1Nicholas D Huntington, Hamsa Puthalakath, Priscilla Gunn, et al.
Nature Communications|November 12, 2021
Mesenchymal stromal cell apoptosis is required for their therapeutic functionSwee Heng Milon Pang, Joshua D'Rozario, Senora Mendonca, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2011
Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1Ben A Croker, Joanne A O'Donnell, Cameron J Nowell, et al.
Genes & Development|May 21, 2016
Physiological restraint of Bak by Bcl-xL is essential for cell survivalErinna F Lee, Stephanie Grabow, Stephane Chappaz, et al.
Cell Death and Differentiation|October 25, 2019
EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteinsLeah Fitzsimmons, Rachel Cartlidge, Catherine Chang, et al.
Elife|November 19, 2015
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cellMichael J Coffey, Brad E Sleebs, Alessandro D Uboldi, et al.
Molecular Cell|November 18, 2017
Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based DesignJason M Brouwer, Ping Lan, Angus D Cowan, et al.
Nature Structural & Molecular Biology|September 15, 2020
BAK core dimers bind lipids and can be bridged by themAngus D Cowan, Nicholas A Smith, Jarrod J Sandow, et al.
Science Translational Medicine|August 4, 2017
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancerDelphine Merino, James R Whittle, François Vaillant, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
The EMBO Journal|September 15, 2021
Dynamic reconfiguration of pro-apoptotic BAK on membranesJarrod J Sandow, Iris Kl Tan, Alan S Huang, et al.
Nature Immunology|July 10, 2007
Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1Nicholas D Huntington, Hamsa Puthalakath, Priscilla Gunn, et al.
Nature Communications|November 12, 2021
Mesenchymal stromal cell apoptosis is required for their therapeutic functionSwee Heng Milon Pang, Joshua D'Rozario, Senora Mendonca, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2011
Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1Ben A Croker, Joanne A O'Donnell, Cameron J Nowell, et al.
Genes & Development|May 21, 2016
Physiological restraint of Bak by Bcl-xL is essential for cell survivalErinna F Lee, Stephanie Grabow, Stephane Chappaz, et al.
Cell Death and Differentiation|October 25, 2019
EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteinsLeah Fitzsimmons, Rachel Cartlidge, Catherine Chang, et al.
Elife|November 19, 2015
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cellMichael J Coffey, Brad E Sleebs, Alessandro D Uboldi, et al.
Molecular Cell|November 18, 2017
Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based DesignJason M Brouwer, Ping Lan, Angus D Cowan, et al.
Nature Structural & Molecular Biology|September 15, 2020
BAK core dimers bind lipids and can be bridged by themAngus D Cowan, Nicholas A Smith, Jarrod J Sandow, et al.
Science Translational Medicine|August 4, 2017
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancerDelphine Merino, James R Whittle, François Vaillant, et al.
Pageof 8